Marianne De Backer

President and CEO

Marianne De Backer (President and CEO) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in VIR. The largest single filing was $665K of VIR (72,559 sh × $9.16, as filed), executed Apr 6.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 3 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$947K

shares × price, as filed

Last traded

Apr 6

Filed Apr 7

Open performance→

Volume by month

Buys $0 Sells $1.6M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Not on file 3 filings

Sector per market data · by filing · past 12 months

Most traded names

VIR VIR VIR · 0 buys · 5 sells 5 filings

Recent filings

VIRSALE Vir Biotechnology, Inc. View filing → $665K
72,559 sh × $9.16
Exec Apr 6
Filed Apr 7 · 5:30 PM ET VIRSALE Vir Biotechnology, Inc. View filing → $141K
14,762 sh × $9.53
Exec Feb 24
Filed Feb 26 · 5:30 PM ET VIRSALE Vir Biotechnology, Inc. View filing → $142K
19,039 sh × $7.45
Exec Feb 23
Filed Feb 24 · 5:30 PM ET VIRSALE Vir Biotechnology, Inc. View filing → $474K
79,712 sh × $5.95
Exec Apr 3 2025
Filed Apr 4 2025 · 5:30 PM ET VIRSALE Vir Biotechnology, Inc. View filing → $152K
16,122 sh × $9.45
Exec Feb 24 2025
Filed Feb 25 2025 · 5:30 PM ET